• Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

  • Mar 27 2023
  • Duración: 15 m
  • Podcast

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

  • Resumen

  • Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

    This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.

    Más Menos

Lo que los oyentes dicen sobre Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.